Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity

Human Gene Therapy

Volumn 8, Issue 1, 1997, Pages 73-85

  Rogulski, Kenneth R ^a   Kim, Jae Ho ^a   Kim, Sang Hie ^a   Freytag, Svend O ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; CYTOSINE DEAMINASE; FLUCYTOSINE; GANCICLOVIR; HYBRID PROTEIN; PRODRUG; THYMIDINE KINASE;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIVITY; ENZYMATIC ASSAY; ESCHERICHIA COLI; GENE EXPRESSION; GENE FUSION; GENETIC TRANSDUCTION; GLIOMA CELL; GLIOSARCOMA; HERPES SIMPLEX VIRUS 1; NONHUMAN; RADIOSENSITIVITY; RETROVIRUS; SUICIDE GENE;

EID: 0031024794     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.1-73     Document Type: Article

References (44)

1. ABBRUZZESE, J.L., and LEVIN, B. (1989). Treatment of advanced colorectal cancer. Hematol. Oncol. Clin. North Am. 3, 135-153.
2. ALBRIGHT, N. (1987). Computer programs for the analysis of cellular survival data. Radiat. Res. 112, 331-340.
3. BALZARINI, J., BOHMAN, C., and DE CLERCQ, E. (1993). Differential mechanisms of cytostatic effect of (E)-5-(2-bromovinyl)-2′-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl) guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2. J. Biol. Chem. 268, 6332-6337.
4. BI, W.L., PARYSEK, L.M., WARNICK, R., and STAMBROOK, P.J. (1993). In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSVtk retroviral gene therapy. Hum. Gene Ther. 4, 725-731.
5. BLACK, P.M. (1991). Brain tumors. N. Engl. J. Med. 324, 1555-1564.
6. BLEIBERG, H. (1989). Treatment of advanced colorectal cancer. Anticancer Res. 9, 1013-1015.
7. BRINSTER, R.L., CHEN, H.Y., and TRUMBAUER, M. (1981). Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs. Cell 27, 223-231.
8. CALABRISI, P., and CHABNER, B.A. (1990). Antineoplastic agents. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed. A.G. Gilman, T. Rall, A.S. Nies, and P. Taylor, eds. (Pergamon, New York, NY) pp. 1209-1263.
9. COOL, V., PIROTTE, B., GERARD, C., DARGENT, J.-L., BAUDSON, N., LEVIVIER, M., GOLDMAN, S., HILDEBRAND, J., BROTCHI, J., and VELU, T. (1996). Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma. Hum. Gene Ther. 7, 627-635.
10. COPUR, S., AIBA, K., DRAKE, J.C., ALLEGRA, C.J., and CHU, E. (1995). Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil. Biochem. Pharmacol. 49, 1419-1426.
11. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
12. DANIELSON, S., KILSTRUP, M., BARILLA, K., JOCHIMSEN, B., and NEUHARD, J. (1992). Characterization of the Escherichia coli codBA operon encoding cytosine permease and cytosine deaminase. Mol. Microbiol. 6, 1335-1344.
13. DONG, Y., WEN, P., MANOME, Y., PARR, M., HIRSHOWITZ, A., CHEN, L., HIRSCHOWITZ, E.A., CRYSTAL, R., WEICHSELBAUM, R., KUFE, D.W., and FINE, H.A. (1996). In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum. Gene Ther. 7, 713-720.
14. EZZEDDINE, Z.D., MARTUZA, R.L., PLATIKA, D., SHORT, M.P., MALICK, A., CHOI, B., and BREAKEFIELD, X.O. (1991). Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. The New Biol. 3, 608-614.
15. FREYTAG, S.O., PAIELLI, D.L., and GILBERT, J.D. (1994). Ectopic expression of the CCAAT/enhancer binding protein α promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes & Dev. 14, 1654-1663.
16. FURMAN, P.A., MCGUJIRT, P.V., KILLER, P.M., FYFE, J.A., and ELION, G.B. (1980). Inhibition by acyclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information. Virology 102, 420-430.
17. GOLUMBEK, P.T., HAMZEH, F.M., JAFFEE, E.M., LEVITSKY, H., LIETMAN, P.S., and PARDOLL, D.M. (1992). Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccines. J. Immunother. 12, 224-230.
18. HALL, E.J. (1994). Radiobiology for the Radiobiologist. (J.B. Lippincott Co., Philadelphia, PA).
19. HIRSCHOWITZ, E.A., OHWADA, A., PASCAL, W.R., RUSSI, T.J., and CRYSTAL, R.G. (1995). In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum. Gene Ther. 6, 1055-1063.
20. HOGANSON, D.K., BATRA, R.K., OLSEN, J.C., and BOUCHER, R.C. (1996). Comparison of the effects of three different toxin genes and their levels of expression on cell growth and bystander effect in lung adenocarcinoma. Cancer Res. 56, 1315-1323.
21. HUBER, B.E., AUSTIN, E.A., GOOD, S.S., KNICK, V.C., TIBBELS, S., and RICHARDS, C.A. (1993). In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res. 53, 4619-4626.
22. HUBER, B.E., AUSTIN, E.A., RICHARDS, C.A., DAVIS, S.T., and GOOD, S.S. (1994). Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc. Natl. Acad. Sci. USA 91, 8302-8306.
23. KHIL, M.S., KIM, J.H., MULLEN, C.A., KIM, S.H., and FREYTAG, S.O. (1996). Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene. Clin. Cancer Res. 2, 53-57.
24. KIM, J.H., KIM, S.H., BROWN, S.L., and FREYTAG, S.O. (1994). Selective enhancement by an antiviral agent of the radiation-induced cell killing of human glioma cells transduced with HSV-tk gene. Cancer Res. 54, 6053-6056.
25. KIM, J.H., KIM, S.H., KOLOZSVARY, A., BROWN, S.L., KIM, O.B., and FREYTAG, S.O. (1995). Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents. Int. J. Radiat. Oncol. Biol. Phys. 33, 861-868.
26. MANOME, Y., ABE, M., HAGEN, M.F., FINE, H.A., and KUFE, D.W. (1994). Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir. Cancer Res. 54, 5408-5413.
27. MARKOWITZ, D., GOFF, S., and BANK, A. (1988). A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62, 1120-1124.
28. McBRIDE, W.H., and DOUGHERTY, G.J. (1995). Radiotherapy for genes that cause cancer. Nature Med. 1, 1215-1217.
29. MILLER, A.D., and BUTTIMORE, C. (1986). Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6, 2895-2902.
30. MOOLTEN, F.L. (1994). Drug sensitivity ("suicide") genes for selective cancer chemotherapy. Cancer Gene Ther. 1, 279-287.
31. MOOLTEN, F.L., and WELLS, J.M. (1990). Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst. 82, 297-300.
32. MORGAN, R.A., COUTURE, L., ELROY-STEIN, O., RAGHEB, J., MOSS, B., and ANDERSON, W.F. (1992). Retroviral vectors containing putative internal ribosome entry sites: Development of a polycistronic gene transfer system and applications to human gene therapy. Nucleic Acids Res. 20, 1293-1299.
33. MULLEN, C.A. (1994). Metabolic suicide genes in gene therapy. Pharmac. Ther. 63, 199-207.
34. MULLEN, C.A., KILSTRUP, M., and BLAESE, R.M. (1992). Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system. Proc. Natl. Acad. Sci. USA 89, 33-37.
35. MULLEN, C.A., COALE, M.M., LOWE, R., and BLAESE, R.M. (1994). Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res. 54, 1503-1506.
36. RAM, Z., CULVER, K.W., WALLBRIDGE, S., BLAESE, R.M., and OLDFIELD, E.H. (1993). In situ retroviral mediated gene transfer for the treatment of brain tumors. Cancer Res. 53, 83-88.
37. RICHARDS, C.A., AUSTIN, E.A., and HUBER, B.A. (1995). Transcriptional regulatory sequences of carcinoembryonic antigen: Identification and use with cytosine deaminase for tumor-specific gene therapy. Hum. Gene Ther. 6, 881-893.
38. SHORT, M.P., CHOI, B.C., LEE, J.K., MALICK, A., BREAKEFIELD, X.O., and MARTUZA, R.L. (1990). Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J. Neurosci. Res. 27, 427-439.
39. 125I]deoxycytidine used in a rapid, sensitive, and specific assay for herpes simplex virus type 1 thymidine kinase. J. Virol. 24, 314-318.
40. TAKAMIYA, Y., SHORT, M.P., EZZEDDINE, Z.D., MOOLTEN, F.L., BREAKEFIELD, X.O., and MARTUZA, R.L. (1992). Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J. Neurosci. Res. 33, 493-503.
41. TAKAMIYA, Y., SHORT, M.P., MOOLTEN, F.I., FLEET, C., MINETA, T., BREAKEFIELD, X.O., and MARTUZA, R.L. (1993). An experimental model of retrovirus gene therapy for malignant brain tumors. J. Neurosurg. 79, 104-110.
42. TIBERGHIEN, P. (1994). Use of suicide genes in gene therapy. J. Leuk. Biol. 56, 203-209.
43. TRINH, Q.T., AUSTIN, E.A., MURRAY, D.M., KNICK, V.C., and HUBER, B.A. (1995). Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Cancer Res. 55, 4808-4812.
44. WU, J.K., CANO, W.G., MEYLAERTS, S.A.G., QI, P., VRIONIS, F., and CHERINGTON, V. (1994). Bystander tumoricidal effect in the treatment of experimental brain tumors. Neurosurgery 35, 1094-1103.